Notably, the Ozempic group showed an HR of 1.72 (95% CI 1.671.76), and the Wegovy group presented a significantly higher HR of 2.14 (95% CI 2.052.24)
GLP-1 RA-based therapy has introduced a new era in the treatment of overweight and obesity, which is reflected in numerous clinical trials and patient-reported outcomes, highlighting its efficacy and safety profile (Kushner et al
The most severe side effects were seen with diarrhea
The right dietary approach can enhance the medication's effectiveness, help manage common side effects, ensure adequate nutrition despite reduced intake, and lay the foundation for maintaining weight loss long-term
Your promise: Never stress about "what's for lunch" again
GLP-1 medications work differently because they alter the biological reward system directly